DMD progression found to vary greatly among patients
In Duchenne muscular dystrophy (DMD), the age when symptoms start and how quickly they get worse can be very different from person to person.
In Duchenne muscular dystrophy (DMD), the age when symptoms start and how quickly they get worse can be very different from person to person.
Boys with DMD have a harder time doing two things at once than their peers without the disease, negatively affecting everyday life.
Muscle weakness in Duchenne muscular dystrophy (DMD) does not follow a simple decline, but has periods of stability before worsening.
Mice studies show that the activation of endogenous utrophin is a promising therapeutic strategy in alleviating DMD symptoms.
The lack of clear information combined with the limited treatments for DMD impact shared decision making between families and providers.
A new study suggests that some female carriers of Duchenne muscular dystrophy (DMD) mutations experience symptoms and complications.
A 16-year-old boy with Duchenne muscular dystrophy (DMD) died of acute liver failure several months after receiving Elevidys, a gene therapy.
A recent systematic review highlighted the risks associated with various anesthetic techniques in patients with DMD.
Parents of patients with DMD exhibit some positive psychological and emotional growth, but would benefit from better support systems.
Young adults with DMD want to live meaningful, independent adult lives, but face challenges in social participation.